soul trial oral semaglutide cardiovascular outcomes results 2024 2025 PDF) and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized SOUL trial shows oral semaglutide

All of them matter for metabolic health

Your appetite drops so much that reaching your protein goals takes extra effort

This once-weekly injection employs the same GLP-1 science as Ozempic but is specifically directed at chronic weight management

Supports insulin function and glucose balance

Currently Available Treatment Tirzepatide FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential Retatrutide Phase 3 TRIUMPH-4 data showed 28.7% weight loss at 68 weeks (24.2% at 48 weeks in Phase 2), exceeding tirzepatide's results Non-Alcoholic Fatty Liver Disease Retatrutide Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management Tirzepatide Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly

A truly effective support system must look at the whole picture